Press Releases

Asensus Surgical, Inc. to Present at the LD Micro Main Event XV Presentation on Tuesday, October 25 at 8:30 am PT RESEARCH TRIANGLE PARK, N.C. , October 18, 2022 (GLOBE NEWSWIRE) – via NEWMEDIAWIRE –  Asensus Surgical, Inc. (NYSE American: ASXC), Asensus Surgical, a medical device company that is

System to be Utilized by the Oncology-Focused Clinic for General and Visceral Surgery RESEARCH TRIANGLE PARK, N.C. , Sept. 28, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to

RESEARCH TRIANGLE PARK, N.C. , Sept. 09, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced Saiseikai Shiga Hospital

Evangelical Hospital Goettingen-Weende to become 7th Senhance Hospital in Germany RESEARCH TRIANGLE PARK, N.C. , Aug. 31, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a

RESEARCH TRIANGLE PARK, N.C. , Aug. 30, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando , President and Chief Executive Officer and Shameze Rampertab , Executive Vice President and Chief Financial Officer, will participate in the H. C .

RESEARCH TRIANGLE PARK, N.C. , Aug. 08, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and

Senhance System to be placed at hospital in the Commonwealth of Independent States RESEARCH TRIANGLE PARK, N.C. , Aug. 04, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer

RESEARCH TRIANGLE PARK, N.C. , July 26, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release

This becomes the 6th Senhance Hospital in Germany RESEARCH TRIANGLE PARK, N.C. , July 07, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided

RESEARCH TRIANGLE PARK, N.C. , June 28, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the Company will be